Consumer

We advised Well Pharmacy, now Bestway Healthcare.... Read more

We advised Well Pharmacy, now Bestway Healthcare (a subsidiary of Bestway Group), on its acquisition of Lexon, a leading family-owned pharmaceutical wholesaler and generic medicines manufacturer. Lexon operates nationally, serving independent community pharmacies across the UK as well as operating over 40 community pharmacies of its own.

The transaction strengthens Bestway Healthcare’s growth momentum to bring enhanced benefits to its customers and patients across the UK.

Lawyers in our London office led the transaction, with support from our commercial, employment, finance, insurance, intellectual property, pensions, privacy and cybersecurity, tax, real estate, and regulatory practices.

We advised Sovos Brands, Inc., a maker... Read more

We advised Sovos Brands, Inc., a maker of premium branded food, on its sale to Campbell Soup Company, representing a total enterprise value of approximately US$2.7 billion.

The transaction adds a high-growth, market-leading premium portfolio of brands to diversify and enhance Campbell’s Meals & Beverages division.

Lawyers in our Silicon Valley office led the transaction, with support from our Denver, Los Angeles, New York, Philadelphia, San Francisco, and Washington, D.C. offices and our antitrust, banking, capital markets, employee benefits, employment, privacy and cybersecurity, regulatory, securities, and tax practices.

We advised Tyson Foods, one of the world’s largest food companies.... Read more

We advised Tyson Foods, one of the world’s largest food companies, on its strategic partnership with Protix, a Netherlands-based leader in global insect ingredients.

The strategic partnership, which represents Tyson Foods’ commitment to continuous innovation, business growth, and working towards sustainable solutions, is expected to accelerate Protix’s international expansion.

Lawyers in our Amsterdam office led the transaction, with support from our Baltimore office and our tax practice.

We advised Walmart Inc., a tech-powered.... Read more

We advised Walmart Inc., a tech-powered omnichannel multinational retailer, on its strategic partnership with SES-imagotag, a French technology company and global leader in digital solutions for physical retail.

The strategic partnership allows Walmart to deploy the latest generation of SES-imagotag’s VUSION platform to further digitize its shelves in hundreds of stores across the United States and enhance the customer experience.

Lawyers in our Paris office led the transaction, with support from our private equity and tax practices.

Sector performance

Driven by macroeconomic factors, geopolitical challenges, and continued supply chain disruptions, 2023 consumer M&A deal activity failed to bounce back from its decline in 2022. High inflation and other cost pressures facing consumer companies also hindered a more robust recovery.

As dealmakers navigated regulatory hurdles and high interest rates, the beginnings of a rebound emerged. Led by established corporates, particularly in the food and beverage space, along with players in luxury fashion and pet care, the second half of 2023 provided glimpses of a more active M&A market.


Hogan Lovells activities

In 2023, our Consumer team supported clients to achieve significant digital advancements, navigate ever-evolving regulatory landscapes, and develop strategies to deliver on ESG goals and commitments.

We helped clients around the globe navigate critical issues impacting consumer companies, such as increased regulation of cosmetics and personal care products, the utilization of NFTs and AI in the luxury space, and workforce, privacy, and supply chain issues. We also contributed to the global guidebook Getting the Deal Through – Luxury and Fashion.

The team has knowledge, people, and resources in any jurisdiction. Their depth of knowledge and bench strength is so important.”

Chambers USA, 2023

650+

Consumer lawyers

Band 1

Food and Beverage: Regulatory and Litigation
Chambers USA, 2023

Our four pillars

Technical Excellence

Technical excellence

Executing transactions effectively

Industry Knowledge

Industry knowledge

Understanding issues in regulated industries

Global Reach

Global reach

Worldwide reach,
local knowledge

Full-Service capabilities

Full-service capabilities

Subject matter knowledge

M&A Year in Review

Expander

Dear Clients and Friends,

Welcome to the 10th edition of our Hogan Lovells M&A Year in Review! We created our M&A Year in Review to express our gratitude to you – our clients and friends – for the opportunity to work together and for the successes that we have shared. We hope you enjoy our review of dealmaking during 2023 and our projections for M&A during 2024.

Global M&A activity in 2023 slowed to a 10-year low. Aggregate deal volume decreased by 6%, to a three-year low, and aggregate deal value declined by 17%, marking the first time global deal value failed to reach US$3 trillion since 2013. 

A combination of factors led to this decline in dealmaking, including persistent inflation, heightened cost of capital, increased regulatory scrutiny, fears of recession, and conflicts in Europe and the Middle East.

During 2023, sponsor-related M&A experienced a significant downturn in both volume and value, with deal value falling 40% and deal volume down 26%. For strategic M&A, deal value declined by 3% from 2022, and the number of strategic deals declined 13% during the same period.

Sector activity varied widely during 2023. M&A in the energy and power sector propelled the conversion from traditional to clean energy, with transaction value exceeding more than US$500 billion and accounting for 17% of overall M&A value. The technology sector experienced a 47% decline in M&A value compared to 2022, as companies and investors pursued smaller transactions driven by technology imperatives. Life sciences and health care M&A remained vibrant in 2023, with deal value increasing by 23% compared to 2022 – a trend driven by high-value transactions in the biotech and pharmaceutical sectors.

Our M&A Group is grateful to have worked with you over the course of 2023. Your transactions propelled Hogan Lovells to more than 30 M&A league table rankings worldwide, including for Global M&A and across Europe, France, Germany, Italy, the Nordics, the United States, Latin America, Asia, Australia, and India.

For the year ahead, we forecast measured optimism for meaningful increases in deal value and deal volume, as set forth within our 2024 M&A Outlook.

We appreciate the trust that you continue to place in us, and we look forward to supporting you on your M&A transactions in the year ahead.

Best wishes for continuing success in 2024,

The Hogan Lovells M&A Group